NCT00784680View on ClinicalTrials.gov

ATAC - Quality of Life Sub-Protocol

PHASE3CompletedINTERVENTIONAL

Enrollment

308

Participants

Timeline

Start Date

April 30, 1998

Study Completion Date

April 30, 2004

Conditions

Quality of Life

Interventions

DRUG

Anastrozole

1mg, orally, once daily

DRUG

Tamoxifen

20mg, orally, once daily

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY